Cargando…
Peptidomimetic plasmepsin inhibitors with potent anti-malarial activity and selectivity against cathepsin D
Following up the open initiative of anti-malarial drug discovery, a GlaxoSmithKline (GSK) phenotypic screening hit was developed to generate hydroxyethylamine based plasmepsin (Plm) inhibitors exhibiting growth inhibition of the malaria parasite Plasmodium falciparum at nanomolar concentrations. Lea...
Autores principales: | Zogota, Rimants, Kinena, Linda, Withers-Martinez, Chrislaine, Blackman, Michael J., Bobrovs, Raitis, Pantelejevs, Teodors, Kanepe-Lapsa, Iveta, Ozola, Vita, Jaudzems, Kristaps, Suna, Edgars, Jirgensons, Aigars |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Editions Scientifiques Elsevier
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6336538/ https://www.ncbi.nlm.nih.gov/pubmed/30529637 http://dx.doi.org/10.1016/j.ejmech.2018.11.068 |
Ejemplares similares
-
Macrocyclic
Peptidomimetic Plasmepsin X Inhibitors
with Potent In Vitro and In Vivo Antimalarial Activity
por: Kovada, Vadims, et al.
Publicado: (2023) -
3-(Adenosylthio)benzoic Acid Derivatives as SARS-CoV-2 Nsp14 Methyltransferase Inhibitors
por: Bobileva, Olga, et al.
Publicado: (2023) -
Potent SARS-CoV-2 mRNA Cap Methyltransferase
Inhibitors by Bioisosteric Replacement of Methionine in SAM Cosubstrate
por: Bobiļeva, Olga, et al.
Publicado: (2021) -
Discovery of SARS-CoV-2 Nsp14 and Nsp16 Methyltransferase Inhibitors by High-Throughput Virtual Screening
por: Bobrovs, Raitis, et al.
Publicado: (2021) -
May 1,2-Dithiolane-4-carboxylic Acid and Its Derivatives Serve as a Specific Thioredoxin Reductase 1 Inhibitor?
por: Nikitjuka, Anna, et al.
Publicado: (2023)